Celularity Inc.
CELU
$0.69
-$0.12-15.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.10M | 5.28M | 5.74M | 11.43M | 18.13M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.10M | 5.28M | 5.74M | 11.43M | 18.13M |
| Cost of Revenue | 7.37M | 3.90M | 5.24M | 3.55M | 7.34M |
| Gross Profit | -3.27M | 1.38M | 494.00K | 7.87M | 10.79M |
| SG&A Expenses | 15.06M | 9.31M | 12.63M | 14.26M | 16.06M |
| Depreciation & Amortization | -1.48M | 325.00K | 372.00K | 368.00K | 376.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.30M | 18.13M | 21.60M | 21.91M | 27.61M |
| Operating Income | -20.20M | -12.85M | -15.86M | -10.49M | -9.47M |
| Income Before Tax | -24.36M | -23.08M | -24.52M | -19.75M | -13.29M |
| Income Tax Expenses | 3.00K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.36M | -23.08M | -24.52M | -19.75M | -13.29M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.36M | -23.08M | -24.52M | -19.75M | -13.29M |
| EBIT | -20.20M | -12.85M | -15.86M | -10.49M | -9.47M |
| EBITDA | -18.85M | -11.08M | -14.03M | -8.65M | -7.60M |
| EPS Basic | -0.86 | -0.88 | -1.02 | -0.84 | -0.60 |
| Normalized Basic EPS | -0.42 | -0.54 | -0.61 | -0.37 | -0.38 |
| EPS Diluted | -0.86 | -0.88 | -1.02 | -0.84 | -0.60 |
| Normalized Diluted EPS | -0.42 | -0.54 | -0.61 | -0.37 | -0.38 |
| Average Basic Shares Outstanding | 28.45M | 26.35M | 24.02M | 23.53M | 22.29M |
| Average Diluted Shares Outstanding | 28.45M | 26.35M | 24.02M | 23.53M | 22.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |